AbbVie
ABBV
#28
Rank
โ‚ฌ337.60 B
Marketcap
191,24ย โ‚ฌ
Share price
1.79%
Change (1 day)
17.66%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total debt

Total debt on the balance sheet as of September 2024 : โ‚ฌ67.66 Billion

According to AbbVie's latest financial reports the company's total debt is โ‚ฌ67.66 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

AbbVie - Total debt on balance sheet (from 2011 to 2024)

Total debt by year

Year Total debt Change
2023-12-31โ‚ฌ53.71 B-8.93%
2022-12-31โ‚ฌ58.98 B-12.89%
2021-12-31โ‚ฌ67.71 B-3.22%
2020-12-31โ‚ฌ69.96 B17.46%
2019-12-31โ‚ฌ59.56 B69.05%
2018-12-31โ‚ฌ35.23 B13.14%
2017-12-31โ‚ฌ31.14 B-11.08%
2016-12-31โ‚ฌ35.02 B20.92%
2015-12-31โ‚ฌ28.96 B135.22%
2014-12-31โ‚ฌ12.31 B15.51%
2013-12-31โ‚ฌ10.66 B-10.02%
2012-12-31โ‚ฌ11.84 B31954.69%
2011-12-31โ‚ฌ36.96 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
โ‚ฌ63.41 B-6.28%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ48.74 B-27.97%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ29.62 B-56.22%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ57.49 B-15.03%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ22.13 B-67.29%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.31 B-90.67%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ20.46 B-69.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ28.66 B-57.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ0.43 B-99.36%๐Ÿ‡บ๐Ÿ‡ธ USA